Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 854

1.

The Simultaneous Elevation of Oxidative Stress Markers and Wilms' Tumor 1 Gene during the Progression of Myelodysplastic Syndrome.

Shimizu N, Hasunuma H, Watanabe Y, Matsuzawa Y, Iwashita Y, Tatsuno I, Yokota H.

Intern Med. 2016;55(24):3661-3664. Epub 2016 Dec 15.

2.

The association between nephroblastoma-specific outcomes and high versus low volume treatment centers.

Richards MK, Goldin AB, Savinkina A, Doski J, Goldfarb M, Nuchtern J, Langer M, Beierle EA, Vasudevan S, Gow KW, Raval MV.

J Pediatr Surg. 2017 Jan;52(1):104-108. doi: 10.1016/j.jpedsurg.2016.10.029. Epub 2016 Oct 27.

PMID:
27836364
3.

WTAP Expression Predicts Poor Prognosis in Malignant Glioma Patients.

Xi Z, Xue Y, Zheng J, Liu X, Ma J, Liu Y.

J Mol Neurosci. 2016 Oct;60(2):131-6. doi: 10.1007/s12031-016-0788-6. Epub 2016 Jul 2.

PMID:
27370540
4.

Construction of a protein-protein interaction network of Wilms' tumor and pathway prediction of molecular complexes.

Teng WJ, Zhou C, Liu LJ, Cao XJ, Zhuang J, Liu GX, Sun CG.

Genet Mol Res. 2016 May 23;15(2). doi: 10.4238/gmr.15028365.

5.

The History of Multimodal Treatment of Wilms' Tumor.

Nakayama DK, Bonasso PC.

Am Surg. 2016 Jun;82(6):487-92.

PMID:
27305878
6.

Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.

Mo XD, Qin YZ, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Liu KY, Huang XJ.

Ann Hematol. 2016 Aug;95(8):1233-40. doi: 10.1007/s00277-016-2706-y. Epub 2016 Jun 14.

PMID:
27302479
7.

Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.

Qi C, Hu Y, Yang F, An H, Zhang J, Jin H, Guo F.

J Pediatr Surg. 2016 Sep;51(9):1501-6. doi: 10.1016/j.jpedsurg.2016.04.016. Epub 2016 May 4.

PMID:
27230801
8.

Down-regulatory mechanism of mammea E/BB from Mammea siamensis seed extract on Wilms' Tumor 1 expression in K562 cells.

Rungrojsakul M, Katekunlaphan T, Saiai A, Ampasavate C, Okonogi S, Sweeney CA, Anuchapreeda S.

BMC Complement Altern Med. 2016 May 18;16:130. doi: 10.1186/s12906-016-1107-z.

9.

Measurement of glomerular filtration rate by dynamic contrast-enhanced magnetic resonance imaging using a subject-specific two-compartment model.

Tipirneni-Sajja A, Loeffler RB, Oesingmann N, Bissler J, Song R, McCarville B, Jones DP, Hudson M, Spunt SL, Hillenbrand CM.

Physiol Rep. 2016 Apr;4(7). pii: e12755. doi: 10.14814/phy2.12755. Epub 2016 Apr 13.

10.

Mutations in WT1 in boys with sporadic isolated steroid-resistant nephrotic syndrome.

Yang Y, Zhao F, Tu X, Yu Z.

Genet Mol Res. 2016 Mar 11;15(1):15017559. doi: 10.4238/gmr.15017559.

11.

Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases.

Björnsson B, Sparrelid E, Hasselgren K, Gasslander T, Isaksson B, Sandström P.

Scand J Surg. 2016 Sep;105(3):158-62. doi: 10.1177/1457496915613650. Epub 2016 Feb 29.

PMID:
26929296
12.

Pulmonary metastasectomy in pediatric patients.

Erginel B, Gun Soysal F, Keskin E, Kebudi R, Celik A, Salman T.

World J Surg Oncol. 2016 Feb 2;14(1):27. doi: 10.1186/s12957-016-0788-6.

13.

Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer.

Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, Stovall M, Oeffinger KC, Bhatia S, Krull KR, Nathan PC, Neglia JP, Green DM, Hudson MM, Robison LL.

N Engl J Med. 2016 Mar 3;374(9):833-42. doi: 10.1056/NEJMoa1510795. Epub 2016 Jan 13.

14.

Prevalence and Prognostic Impact of Wilms' Tumor 1 (WT1) Gene, Including SNP rs16754 in Cytogenetically Normal Acute Myeloblastic Leukemia (CN-AML): An Iranian Experience.

Toogeh G, Ramzi M, Faranoush M, Amirizadeh N, Haghpanah S, Moghadam M, Cohan N.

Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):e21-6. doi: 10.1016/j.clml.2015.11.017. Epub 2015 Nov 22.

PMID:
26725263
15.

The roles of microRNAs in Wilms' tumors.

Yu X, Li Z, Chan MT, Wu WK.

Tumour Biol. 2016 Feb;37(2):1445-50. doi: 10.1007/s13277-015-4514-8. Epub 2015 Dec 3. Review.

PMID:
26634744
16.

Comparative study of quality of life of adult survivors of childhood acute lymphocytic leukemia and Wilms' tumor.

Souza CM, Cristofani LM, Cornacchioni AL, Odone Filho V, Kuczynski E.

Einstein (Sao Paulo). 2015 Oct-Dec;13(4):492-9. doi: 10.1590/S1679-45082015AO3231. Epub 2015 Oct 30. English, Portuguese.

17.

Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation.

Casalegno-Garduño R, Schmitt A, Spitschak A, Greiner J, Wang L, Hilgendorf I, Hirt C, Ho AD, Freund M, Schmitt M.

Int J Cancer. 2016 Apr 1;138(7):1792-801. doi: 10.1002/ijc.29909. Epub 2015 Nov 27.

18.

Assessment of Relationship between Wilms' Tumor Gene (WT1) Expression in Peripheral Blood of Acute Leukemia Patients and Serum IL-12 and C3 Levels.

Rezai O, Khodadadi A, Heike Y, Mostafai A, Gerdabi ND, Rashno M, Abdoli Z.

Asian Pac J Cancer Prev. 2015;16(16):7303-7.

19.

Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy.

Tsukinaga S, Kajihara M, Takakura K, Ito Z, Kanai T, Saito K, Takami S, Kobayashi H, Matsumoto Y, Odahara S, Uchiyama K, Arakawa H, Okamoto M, Sugiyama H, Sumiyama K, Ohkusa T, Koido S.

World J Gastroenterol. 2015 Oct 21;21(39):11168-78. doi: 10.3748/wjg.v21.i39.11168.

20.

WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.

Masserot C, Liu Q, Nguyen E, Gattolliat CH, Valteau-Couanet D, Bénard J, Huber C, Ségal-Bendirdjian E.

Mol Oncol. 2016 Feb;10(2):240-52. doi: 10.1016/j.molonc.2015.09.010. Epub 2015 Oct 21.

Supplemental Content

Loading ...
Support Center